| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/03/2006 | CN1254243C Pharmaceutical compositions comprising chelidonine or derivatives thereof |
| 05/02/2006 | US7038052 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037915 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006029146A3 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS |
| 04/27/2006 | US20060089397 Synthetic diazonamides |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089262 Substituted (thioxo)carbonylamino phenyl uraciles |
| 04/27/2006 | CA2584507A1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 04/26/2006 | EP1650235A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 04/26/2006 | EP1648923A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 04/26/2006 | EP1648905A1 Thienopyridine and furopyridine kinase inhibitors |
| 04/26/2006 | EP1648904A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 04/26/2006 | EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 04/26/2006 | EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 04/26/2006 | EP1409485B1 Immunomodulating compounds |
| 04/26/2006 | CN1764663A Method for preparing topotecan from 10-hydroxy-4-(S)-camptothecine |
| 04/26/2006 | CN1764662A Cyclic benzimidazoles. |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors |
| 04/26/2006 | CN1763042A Preparation method of indole-containing heterocycle pyridinedihydrofuranketone |
| 04/26/2006 | CN1253455C 2-3-methylen-dioxy dibenzo [a,g] quinolizine onium hydrochloride and its uses in treatment of diabete |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/25/2006 | US7034163 From alkoxycyclopropane with nitrile in presence of Lewis acid catalyst |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034041 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | CA2189525C 2-(aminomethyl)-3,4,7,9-tetrahydro-2h-pyrano-[2,3e]indol-8-ones and derivatives |
| 04/20/2006 | WO2006041872A2 Thrombin receptor antagonists |
| 04/20/2006 | WO2006040351A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 04/20/2006 | WO2006040338A1 Difluoro-substituted imidazopyridines |
| 04/20/2006 | WO2005115398A3 Hiv integrase inhibitors |
| 04/20/2006 | WO2005111039A3 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/20/2006 | WO2005016913A8 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| 04/20/2006 | US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 04/20/2006 | US20060084576 Hetaryl substituted homotetramic and homotetronic acids and their use thereof as pesticides |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | CA2583253A1 Difluoro-substituted imidazopyridines |
| 04/20/2006 | CA2582639A1 Thrombin receptor antagonists |
| 04/20/2006 | CA2582180A1 Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents |
| 04/19/2006 | EP1647549A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents |
| 04/19/2006 | EP1646661A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/19/2006 | EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 04/19/2006 | EP1646388A2 Cytotoxic indeno and isoindoloisoquinolones |
| 04/19/2006 | EP1646380A2 Indolocarbazole anticancer agents and methods of using same |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1363883B1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith |
| 04/19/2006 | EP1080726B1 Agents for relieving side effects |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1761667A 3-phenyl substituted 3-substituted-4ketolactams and ketolactones |
| 04/19/2006 | CN1761660A Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 04/19/2006 | CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 04/19/2006 | CN1760195A Method for separating and purifying 9-nitro camptothecin |
| 04/18/2006 | US7030245 A chemical intermediate, toluene-4-sulfonic acid 7,8-dihydro-6H-5-oxa-1-aza-phenanthren-6-ylmethyl ester for preparing antidepressant, 6-[4-(5-fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-ylmethyl]-7,8-dihydro-6H-5-oxa-1aza-phenanthrene; treating psychological disorders |
| 04/18/2006 | US7030243 Process for making camptothecin derivatives |
| 04/18/2006 | US7030196 Process for reducing the molecular weight of polypropylene |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | CA2247513C Camptothecin derivatives and the use thereof as antitumor agents |
| 04/18/2006 | CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 04/18/2006 | CA2207443C Tricyclic compounds |
| 04/13/2006 | WO2006038596A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 04/13/2006 | WO2006038526A1 Acid addition salt of irinotecan |
| 04/13/2006 | US20060079567 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060078518 Cosmetic compositions containing fluorescent colorants for natural skin appearance |
| 04/13/2006 | CA2582615A1 Pharmaceutical composition for treatment of tear and salivary fluid drying |
| 04/13/2006 | CA2582294A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 04/12/2006 | EP1644372A2 Substituted quinolin-4-ylamine analogues |
| 04/12/2006 | EP1644363A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/12/2006 | EP1644343A1 5-substituted quinazolinone derivatives |
| 04/12/2006 | EP1644012A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 04/12/2006 | EP1644001A2 Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1643984A2 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 04/12/2006 | EP1546151B1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| 04/12/2006 | EP1349854B1 Hetaryl substituted homotetramic and homotetronic acids and the use thereof as pesticides |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | CN1759110A Pyrazole derivative |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250550C Process for preparation of amidine derivatives |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250542C 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
| 04/12/2006 | CN1250293C Drug composites |
| 04/11/2006 | US7026489 e.g., (9R)-1-{(2'S,8'S,10'S,11'R)-2',8'-dihydroxy-7'-oxo-11'-[(Z)-2-pentenyl]-9'-oxa-4'-azatricyclo[6.3.1.01.5]dodec-5'-en-10'-yl}-9-hydroxy-10-oxoundecanoic acid and N-[9-hydroxy-10-oxo-12(Z),15(Z)-octadecadienoyl]-L-isoleucine. |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026472 for example 1-(methylthio)-3-methoxy-4-(2-fluorophenyl)azetidin-2-one; induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation |
| 04/11/2006 | US7026341 Hetaryl substituted homotetramic and homotetronic acids and their use thereof as pesticides |
| 04/11/2006 | US7025900 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | US20060074248 Process for the stereoselective synthesis of lactones |